San Daniele del Friuli, Udine, Italy – LimaCorporate and the Hospital for Special Surgery (HSS) are founding the first additive manufacturing (AM) 3D printing facility for custom complex implants in a hospital setting. This collaboration will set the stage to substantially increase the availability and speed of personalized orthopedic care for patients with complex orthopedic conditions in the United States.
HSS, the No. 1-ranked in orthopedics for the past nine years by U.S. News & World Report, has sourced patient-specific custom implants from Lima’s headquarters in Italy since 2016. These devices are intended for treatment of highly complex cases, leveraging Lima’s proprietary Trabecular Titanium material and 3D printing technology. The close proximity of Lima’s AM capabilities to a care environment can significantly help providers who are in turn helping patients.
The new facility, operated by Lima on the HSS main campus on New York’s Upper East Side, will leverage the combination of Lima’s advanced technology and experience, and HSS’ expertise in clinical care and biomechanical engineering. The collaboration will foster and accelerate innovation in complex orthopedic joint care resulting in new products and solutions for patients across the U.S.
Lima has been a pioneer in 3D printing of standard and custom implants for orthopedic applications, boosting more than 10 years of clinical heritage with 3D printed implants.
“The close integration between surgeons and engineers is invaluable for designing and refining joint replacements and identifying new solutions for the most complex patient cases,” says Leonard Achan, RN, MA, ANP, chief innovation officer at HSS.
“We are proud to be the first company to bring 3D printing of implants directly to a hospital organization, where the collaboration between top ranked surgeons and engineers can drive innovation and easier access to patients in the US. This is what defines Lima. A company that has in the past, and will continue in the future, strive to transform orthopedics by challenging the status quo,” said Luigi Ferrari, CEO of LimaCorporate.
Lima will be the registered manufacturer for all devices designed and produced at this new, state-of-the-art facility, located at HSS. The facility is expected to be operational by early 2020 and will initially serve hospitals in the region before making the devices available to all providers in the U.S.